Login

Kuvera co-founder Neelabh Sanyal invests 80% of his portfolio in equities through index funds.|Gaurav Rastogi is the CEO of Kuvera 00:10:00

Share On Facebook Share On Twitter

Gaurav Rastogi is the CEO of Kuvera

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Endeavour Silver - Corporate Overview and Growth Strategy
00:10:00
Surplus Lines Market Sees Record Growth and Evolving Risks, Especially in Cyber Insurance
00:10:00
Value-oriented, and asset-based approach to investing in publicly traded securities|Matthew Fine, Portfolio Manager,Third Avenue Management, LLC
00:10:00
Revolutionizing Investment Research: Take Stock While You Take a Stroll | Tan Teng Boo, CEO ,  Capital Dynamics.
00:10:00
The company specializing in cryptoassets|Linda Xie,Co-Founder and Managing Director,Scalar Capital
00:10:00
Pablo Martín Presents Izertis to Investors at Madrid Stock Exchange Bell Ringing | Pablo Martin, CEO, IZERTIS SA.
00:10:00
Soulful Financial Journey: Insights from Dee Dee Baze on Late-Game Retirement Saving and Tax Wisdom | DeeDee Baze - CEO of Alphemita Financial Services
00:10:00
Ricoh Inc. President and CEO Yoshinori "Jake" Yamashita discusses the company's initiatives and strategies.
00:10:00
Involved in improving the communities around the world|Lee Popkin,Partner,Proskauer Rose LLP
00:10:00
Record-Breaking Gold Export Performance in Ghana for 2024
00:10:00
SPCG's Multifaceted Solar Energy and Infrastructure Ventures under President | Ms. Wandee Kulcharnyakong Chulcharoen, CEO , Spcg PCL .
00:10:00
JAG BHD Stock Analysis: Current Trends and Financial Health Check

© 2017 - Neuhu+